BERZOSERTIB | BERZOSERTIB : Inhibitor of ATR
RATINGS:
Cellular Use: (0 reviews)

In Model Organisms: (0 reviews)
Control Compounds

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
ATR
  • Ki:0.2 nM
  • IC50:19 nM
Inhibitor
up to 100 nM

Selectivity

In Vitro Selectivity Assessment
Selectivity Assessment Description:
VE-822 (0.4 and 2 μM) was screened against a set of human, rat, mouse and fission yeast kinases usin ...

Potency
Cellular
In Vitro

ATR

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1038/cddis.2012.181

In Vivo Validations

Mouse
Dose: 60 mg/Kg
Route of delivery: Oral
Target engagement assay: mice bearing subcutaneous COLO205 tumors

DOI Reference: 10.1158/0008-5472.CAN-13-3369

Chemical Information

Molecular Formula C24H25N5O3S
SMILEs CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1
InChI InChI=1S/C24H25N5O3S/c1-15(2)33(30,31)19-10-8-18(9-11-19)21-14-27-24(25)23(28-21)22-12-20(29-32-22)17-6-4-16(5-7-17)13-26-3/h4-12,14-15,26H,13H2,1-3H3,(H2,25,27)
Molecular weight 463.17 Da
AlogP 0.0
HBond acceptors 8
HBond donors 3
Atoms 58

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


No SERP comments found for BERZOSERTIB

Probe BERZOSERTIB is in the process of SERP review.

Please continue to check back for new reviews and commentary.